Procurement Summary
Country: Brazil
Summary: Acquisition of Medicine(S) Belonging to Group 0936 - Registered Medicines for Specific Purchase, According to Specifications and Quantities Contained in Annex i of the Notice.
Deadline: 26 Jun 2026
Posting Date: 16 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 143397806
Document Ref. No.: 90186/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of medicine(s) belonging to Group 0936 - REGISTERED MEDICINES FOR SPECIFIC PURCHASE, according to specifications and quantities contained in Annex I of the Notice. UASG code: 926119 Notice from: 06/16/2026 from 08:00 to 12:00 and from 13:00 to 17:59 Proposal Delivery: from 06/16/2026 at 08:00 DESVENLAFAXINE, SUCCINATE SALT COMPOSITION, CONCENTRATION 100 MG, PHARMACEUTICAL FORM CONTROLLED RELEASE Quantity: 3240 ESTRADIOL, CONCENTRATION 1 MG/G, GEL PHARMACEUTICAL FORM WITH DOSAGE BOTTLE Quantity: 2160 EVEROLIMO, CONCENTRATION 1 MG Quantity: 10023 EVEROLIMO, CONCENTRATION 1 MG Quantity: 3340 FLUVOXAMINE MALEATE, CONCENTRATION 100 MG Quantity: 2160 GALCANEZUMAB, CONCENTRATION 120 MG/ML, INJECTABLE PHARMACEUTICAL FORM, ADDITIONAL CHARACTERISTICS FILLED SYRINGE Quantity: 36 ELEMENTAL IRON, CONCENTRATION 50 MG/ML, PHARMACEUTICAL FORM ORAL SUSPENSION DROPS Quantity: 36 LEFLUNOMIDE, DOSAGE 20 MG Quantity: 1080 MEDICINAL EXTRACT, ACTIVE PRINCIPLE MATRICARIA CHAMOMILLA L., GLYCYRHIZA GLABRAL., VITS COMPOSITION: C, D, CONCENTRATION 25 MG + 5 MG + 25 MG + 150 IU, PHARMACEUTICAL FORM CAPSULE ORAL USE Quantity: 1440 EXTRACT, COMMON NAME CAMOMILE, BOTANICAL NAME MATRICARIA RECUTITA L., FORM PHARMACEUTICAL OINTMENT Quantity: 36 METHYLFENIDATE HYCLORIDATE, DOSAGE 54 MG, PHARMACEUTICAL FORM CONTROLLED RELEASE Quantity: 4320 OCTREOTIDE, ACETATE SALT COMPOSITION, CONCENTRATION 10 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION, ADDITIONAL CHARACTERISTICS WITH APPLICATION SYSTEM Quantity: 27 OCTREOTIDE, ACETATE SALT COMPOSITION, CONCENTRATION 10 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION, ADDITIONAL CHARACTERISTICS WITH APPLICATION SYSTEM Quantity: 9 ORLISTATE, DOSAGE 120 MG Quantity: 2160
Documents
Tender Notice